224 related articles for article (PubMed ID: 29138117)
1. Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease.
Paul R; Phukan BC; Justin Thenmozhi A; Manivasagam T; Bhattacharya P; Borah A
Life Sci; 2018 Jan; 192():238-245. PubMed ID: 29138117
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease.
Bhattacharjee N; Borah A
Neurochem Int; 2016 Dec; 101():48-55. PubMed ID: 27732886
[TBL] [Abstract][Full Text] [Related]
3. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
4. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
[TBL] [Abstract][Full Text] [Related]
6. Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein.
Brito-Armas JM; Baekelandt V; Castro-Hernández JR; González-Hernández T; Rodríguez M; Castro R
Histol Histopathol; 2013 Aug; 28(8):999-1006. PubMed ID: 23444197
[TBL] [Abstract][Full Text] [Related]
7. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease.
Wang J; He C; Wu WY; Chen F; Wu YY; Li WZ; Chen HQ; Yin YY
Pharmacol Biochem Behav; 2015 Nov; 138():96-103. PubMed ID: 26394281
[TBL] [Abstract][Full Text] [Related]
8. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
9. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.
Xue YQ; Zhao LR; Guo WP; Duan WM
Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174
[TBL] [Abstract][Full Text] [Related]
10. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
11. [Antioxidants prevent experimental hemiparkinsonism in rats].
Talanov SA; Sahach VF
Fiziol Zh (1994); 2008; 54(4):23-9. PubMed ID: 18756771
[TBL] [Abstract][Full Text] [Related]
12. Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism.
Sziráki I; Mohanakumar KP; Rauhala P; Kim HG; Yeh KJ; Chiueh CC
Neuroscience; 1998 Aug; 85(4):1101-11. PubMed ID: 9681949
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Thakur P; Nehru B
Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
[TBL] [Abstract][Full Text] [Related]
14. L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra.
Bhattacharjee N; Mazumder MK; Paul R; Choudhury A; Choudhury S; Borah A
Neurosci Lett; 2016 Aug; 628():225-9. PubMed ID: 27283777
[TBL] [Abstract][Full Text] [Related]
15. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
[TBL] [Abstract][Full Text] [Related]
16. S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2.
García E; Santana-Martínez R; Silva-Islas CA; Colín-González AL; Galván-Arzate S; Heras Y; Maldonado PD; Sotelo J; Santamaría A
Free Radic Res; 2014 Feb; 48(2):159-67. PubMed ID: 24147739
[TBL] [Abstract][Full Text] [Related]
17. Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage.
Liu X; Shao R; Li M; Yang G
Cell Biochem Biophys; 2014 Nov; 70(2):1247-54. PubMed ID: 24948472
[TBL] [Abstract][Full Text] [Related]
18. Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model.
Saravanan KS; Sindhu KM; Mohanakumar KP
J Pineal Res; 2007 Apr; 42(3):247-53. PubMed ID: 17349022
[TBL] [Abstract][Full Text] [Related]
19. Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson's disease.
Bhattacharjee N; Paul R; Giri A; Borah A
Biochem Biophys Rep; 2016 Jul; 6():47-53. PubMed ID: 28955861
[TBL] [Abstract][Full Text] [Related]
20. Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7.
Wang X; Guan Q; Wang M; Yang L; Bai J; Yan Z; Zhang Y; Liu Z
Drug Des Devel Ther; 2015; 9():2553-63. PubMed ID: 26089639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
